A Study Evaluating the Effect of Inhaled PT007(AS MDI) Versus Placebo MDI and Ventolin Evohaler on Lung Function in Adult Participants With Asthma
Clinical trial NCT06644924 · COMPLETED
Trial details
- NCT number
- NCT06644924
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-10
- Primary completion
- 2025-06-04
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.